185 related articles for article (PubMed ID: 19688240)
1. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm.
Aikawa N; Kusachi S; Oda S; Takesue Y; Tanaka H
J Infect Chemother; 2009 Aug; 15(4):219-27. PubMed ID: 19688240
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of micafungin for febrile neutropenia in pediatric patients with hematological malignancies: a multicenter prospective study.
Kobayashi R; Suzuki N; Yoshida M; Iizuka S; Suzuki D; Sano H; Kudoh T
J Pediatr Hematol Oncol; 2013 Oct; 35(7):e276-9. PubMed ID: 23743960
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy of micafungin for chronic pulmonary aspergillosis.
Izumikawa K; Ohtsu Y; Kawabata M; Takaya H; Miyamoto A; Sakamoto S; Kishi K; Tsuboi E; Homma S; Yoshimura K
Med Mycol; 2007 May; 45(3):273-8. PubMed ID: 17464848
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of micafungin in pediatric immunocompromised patients with invasive fungal infection.
Hashii Y; Kusuki S; Takizawa S; Tokimasa S; Ohta H; Hara J; Ozono K
Pediatr Int; 2014 Dec; 56(6):834-837. PubMed ID: 24730676
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study.
Yamaguchi M; Kurokawa T; Ishiyama K; Aoki G; Ueda M; Matano S; Takami A; Yamazaki H; Sawazaki A; Yamauchi H; Yoshida T; Nakao S
Ann Hematol; 2011 Oct; 90(10):1209-17. PubMed ID: 21695388
[TBL] [Abstract][Full Text] [Related]
6. [Antifungal activity and clinical efficacy of micafungin sodium (Funguard)].
Ikeda F
Nihon Yakurigaku Zasshi; 2003 Oct; 122(4):339-44. PubMed ID: 14501170
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the safety and efficacy of micafungin in Japanese patients with deep mycosis: a post-marketing survey report.
Hanadate T; Wakasugi M; Sogabe K; Kobayashi T; Horita H; Kawamura I; Hori Y; Matsui K; Hoshino Y; Sou M
J Infect Chemother; 2011 Oct; 17(5):622-32. PubMed ID: 21437682
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of micafungin, an echinocandin antifungal agent, on invasive fungal infections in patients with hematological disorders.
Tamura K; Urabe A; Yoshida M; Kanamaru A; Kodera Y; Okamoto S; Maesaki S; Masaoka T
Leuk Lymphoma; 2009 Jan; 50(1):92-100. PubMed ID: 19172498
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of micafungin in empirical therapy of deep mycosis in surgically ill patients.
Okamoto K; Katsuki T; Tamura T; Kanemitsu S; Minagawa N; Torigoe T; Shibao K; Higure A; Yamaguchi K
J Infect Chemother; 2012 Oct; 18(5):621-9. PubMed ID: 22450876
[TBL] [Abstract][Full Text] [Related]
10. Safety and Effectiveness of Micafungin in Japanese Pediatric Patients: Results of a Postmarketing Surveillance Study.
Kobayashi C; Hanadate T; Niwa T; Yoshiyasu T; So M; Matsui K
J Pediatr Hematol Oncol; 2015 Jul; 37(5):e285-91. PubMed ID: 25929612
[TBL] [Abstract][Full Text] [Related]
11. [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
Salavert-Lletí M; Zaragoza-Crespo R
Rev Iberoam Micol; 2009 Mar; 26(1):81-9. PubMed ID: 19463284
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
Lee CH; Lin JC; Ho CL; Sun M; Yen WT; Lin C
PLoS One; 2017; 12(7):e0180050. PubMed ID: 28700646
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders.
Yoshida M; Tamura K; Imamura M; Niitsu Y; Sasaki T; Urabe A; Ohyashiki K; Naoe T; Kanamaru A; Tanimoto M; Masaoka T
Ann Hematol; 2012 Mar; 91(3):449-57. PubMed ID: 21894476
[TBL] [Abstract][Full Text] [Related]
14. [Antifungal activity and clinical efficacy of micafungin (funguard)].
Ikeda F
Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of caspofungin or micafungin as empiric antifungal therapy in adult patients with persistent febrile neutropenia: a retrospective, observational, sequential cohort analysis.
Kubiak DW; Bryar JM; McDonnell AM; Delgado-Flores JO; Mui E; Baden LR; Marty FM
Clin Ther; 2010 Apr; 32(4):637-48. PubMed ID: 20435233
[TBL] [Abstract][Full Text] [Related]
16. A prospective, multicenter study of caspofungin for the treatment of documented Candida or Aspergillus infections in pediatric patients.
Zaoutis TE; Jafri HS; Huang LM; Locatelli F; Barzilai A; Ebell W; Steinbach WJ; Bradley J; Lieberman JM; Hsiao CC; Seibel N; Laws HJ; Gamba M; Petrecz M; Taylor AF; Strohmaier KM; Chow JW; Kartsonis NA; Ngai AL
Pediatrics; 2009 Mar; 123(3):877-84. PubMed ID: 19255017
[TBL] [Abstract][Full Text] [Related]
17. Echinocandins: the newest class of antifungals.
Sucher AJ; Chahine EB; Balcer HE
Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of caspofungin in critically ill patients. ProCAS Study.
León-Gil C; Ubeda-Iglesias A; Loza-Vázquez A; de la Torre MV; Raurich-Puigdevall JM; Alvarez-Sánchez B; Ortiz-Leyva C; Domínguez-Roldán JM; Socías-Crespi L; Garnacho-Montero J;
Rev Esp Quimioter; 2012 Dec; 25(4):274-82. PubMed ID: 23303260
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study.
Kohno S; Izumikawa K; Kakeya H; Miyazaki Y; Ogawa K; Amitani R; Niki Y; Kurashima A
Med Mycol; 2011 Oct; 49(7):688-93. PubMed ID: 21355713
[TBL] [Abstract][Full Text] [Related]
20. [Micafungin in pediatric and adolescent patients].
Madero-López L
Rev Iberoam Micol; 2009 Mar; 26(1):62-4. PubMed ID: 19463279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]